179 related articles for article (PubMed ID: 37121958)
1. Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy.
Zhang Z; Shi X; Ji J; Guo Y; Peng Q; Hao L; Xue Y; Liu Y; Li C; Lu J; Yu K
Front Med; 2023 Aug; 17(4):729-746. PubMed ID: 37121958
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma.
Hao L; Guo Y; Peng Q; Zhang Z; Ji J; Liu Y; Xue Y; Li C; Zheng K; Shi X
Phytomedicine; 2022 Feb; 96():153913. PubMed ID: 35026515
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy.
Peng Q; Li S; Shi X; Guo Y; Hao L; Zhang Z; Ji J; Zhao Y; Li C; Xue Y; Liu Y
Phytother Res; 2023 May; 37(5):1740-1753. PubMed ID: 36576358
[TBL] [Abstract][Full Text] [Related]
4. Wolfberry enhanced the abundance of Akkermansia muciniphila by YAP1 in mice with acetaminophen-induced liver injury.
Liu Y; Xue Y; Zhang Z; Ji J; Li C; Zheng K; Lu J; Gao Y; Gong Y; Zhang Y; Shi X
FASEB J; 2023 Jan; 37(1):e22689. PubMed ID: 36468767
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin promoted FXR expression independent of YAP1 in hepatocellular carcinoma.
Guo Y; Peng Q; Hao L; Ji J; Zhang Z; Xue Y; Liu Y; Gao Y; Li C; Shi X
FASEB J; 2022 Jun; 36(6):e22361. PubMed ID: 35616366
[TBL] [Abstract][Full Text] [Related]
6. YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma.
Gao Y; Peng Q; Li S; Zheng K; Gong Y; Xue Y; Liu Y; Lu J; Zhang Y; Shi X
Exp Cell Res; 2023 Mar; 424(1):113486. PubMed ID: 36693491
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin inhibited the Warburg effect through YAP1/SLC2A1 pathway in hepatocellular carcinoma.
Peng Q; Hao L; Guo Y; Zhang Z; Ji J; Xue Y; Liu Y; Li C; Lu J; Shi X
J Nat Med; 2023 Jan; 77(1):28-40. PubMed ID: 36068393
[TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin inhibited interleukin-18 expression by decreasing YAP1 in hepatocellular carcinoma cells.
Gong Y; Peng Q; Gao Y; Yang J; Lu J; Zhang Y; Yang Y; Liang H; Yue Y; Shi X
Acta Histochem; 2023 May; 125(4):152040. PubMed ID: 37119608
[TBL] [Abstract][Full Text] [Related]
9. Lycium barbarum L. Balanced intestinal flora with YAP1/FXR activation in drug-induced liver injury.
Lu J; Gao Y; Gong Y; Yue Y; Yang Y; Xiong Y; Zhang Y; Xiao Y; Wang H; Fan H; Shi X
Int Immunopharmacol; 2024 Mar; 130():111762. PubMed ID: 38428146
[TBL] [Abstract][Full Text] [Related]
10. Wolfberry, Yam, and Chrysanthemum polysaccharides increased intestinal Akkermansia muciniphila abundance and hepatic YAP1 expression to alleviate DILI.
Lu J; Gong Y; Gao Y; Yang Y; Zhang Y; Zhang Z; Shi X
FASEB J; 2023 Dec; 37(12):e23286. PubMed ID: 37950623
[TBL] [Abstract][Full Text] [Related]
11. Akkermansia muciniphila might improve anti-PD-1 therapy against HCC by changing host bile acid metabolism.
Lan X; Ma J; Huang Z; Xu Y; Hu Y
J Gene Med; 2024 Jan; 26(1):e3639. PubMed ID: 38058259
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of
Wu W; Lv L; Shi D; Ye J; Fang D; Guo F; Li Y; He X; Li L
Front Microbiol; 2017; 8():1804. PubMed ID: 29033903
[TBL] [Abstract][Full Text] [Related]
13. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade.
Zhuang Y; Wang Y; Liu C; Li S; Du S; Li G
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):894-905. PubMed ID: 36608830
[TBL] [Abstract][Full Text] [Related]
14. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
15. The role of Akkermansia muciniphila in colorectal cancer: A double-edged sword of treatment or disease progression?
Faghfuri E; Gholizadeh P
Biomed Pharmacother; 2024 Apr; 173():116416. PubMed ID: 38471272
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma.
Zheng Y; Wang T; Tu X; Huang Y; Zhang H; Tan D; Jiang W; Cai S; Zhao P; Song R; Li P; Qin N; Fang W
J Immunother Cancer; 2019 Jul; 7(1):193. PubMed ID: 31337439
[TBL] [Abstract][Full Text] [Related]
17.
Jian H; Liu Y; Wang X; Dong X; Zou X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835309
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1.
Li S; Ji J; Zhang Z; Peng Q; Hao L; Guo Y; Zhou W; Cui Q; Shi X
Mol Cell Biochem; 2020 Dec; 475(1-2):79-91. PubMed ID: 32761300
[TBL] [Abstract][Full Text] [Related]
19.
Hou X; Zhang P; Du H; Chu W; Sun R; Qin S; Tian Y; Zhang Z; Xu F
Front Pharmacol; 2021; 12():725583. PubMed ID: 34603035
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
